11.07.14
On Wednesday Nov. 12th Aurora Spine will be hosting their first annual “Sci Fi” event during this year’s National Association of Spine Surgeons (NASS) Annual Meeting, to be held from Nov. 12-16 in San Francisco, Calif. The event will be a discussion on spine and finance considerations, and will include surgeons and finance professionals speaking on the latest advancements in spinal care and the spinal industry from a finance stand point.
The Carlsbad, Calif.-base spine device company will be presenting its newest devices recently cleared by the U.S. Food and Drug Administration (FDA). The portfolio on display will include eight spinal implants from cervical to minimally invasive surgical (MIS) fusion, as well as the Sentio MMG nerve mapping system along with two new biologic products.
“We are thrilled to present the entire Aurora Spine product portfolio at the 2014 NASS meeting this month, including our new MIS interbody fusion systems featuring Tinano,” said Trent J. Northcutt, president and CEO of Aurora Spine. “We also look forward to meeting the many talented surgeons and distributors that will be attending NASS. One year ago we had one CE marked product available and no FDA clearances. This year we are proud to showcase several FDA cleared products and procedures, all designed to improve spine patient outcomes, drive continued surgeon interests, and provide unique benefits that deliver value to hospitals and patients.”
“We are particularly excited about two new products: Our MIS Interbody Fusion Systems featuring Tinano titanium spray coating technology and our Compass 4D retractor system,” Northcutt continued. “We expect that the new Tinano interbody products will continue to stimulate increased use of our innovative Zip MIS interspinous fusion devices. The enhanced features of the Compass 4D retractor will provide surgeons with the maximum amount of access to the patient’s spine in a safe and reproducible minimally tissue disruptive procedure.”
The Carlsbad, Calif.-base spine device company will be presenting its newest devices recently cleared by the U.S. Food and Drug Administration (FDA). The portfolio on display will include eight spinal implants from cervical to minimally invasive surgical (MIS) fusion, as well as the Sentio MMG nerve mapping system along with two new biologic products.
“We are thrilled to present the entire Aurora Spine product portfolio at the 2014 NASS meeting this month, including our new MIS interbody fusion systems featuring Tinano,” said Trent J. Northcutt, president and CEO of Aurora Spine. “We also look forward to meeting the many talented surgeons and distributors that will be attending NASS. One year ago we had one CE marked product available and no FDA clearances. This year we are proud to showcase several FDA cleared products and procedures, all designed to improve spine patient outcomes, drive continued surgeon interests, and provide unique benefits that deliver value to hospitals and patients.”
“We are particularly excited about two new products: Our MIS Interbody Fusion Systems featuring Tinano titanium spray coating technology and our Compass 4D retractor system,” Northcutt continued. “We expect that the new Tinano interbody products will continue to stimulate increased use of our innovative Zip MIS interspinous fusion devices. The enhanced features of the Compass 4D retractor will provide surgeons with the maximum amount of access to the patient’s spine in a safe and reproducible minimally tissue disruptive procedure.”